On Friday, groups of preschoolers cycled Lake Havasu High School’s hallways for childhood cancer. The event is part of the ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

Notable Labs said it is pausing implementation of the planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The biotechnology company also said Thursday it ...

Coverage from the Institute for Value-Based Medicine session at Ohio State University. This article will appear in the ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...